Data / Form D filings / UBIVAC, INC.
UBIVAC, INC.: Form D filings
UBIVAC, INC., a biotechnology company in Portland, OR, filed 9 Form D notices with the SEC between 2017 and 2026. The latest, on August 27, 2026, reports $80,000 sold of an offering with no set size to 2 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 18183 S.W. BOONES FERRY ROAD, Portland, OR, 97224
- Phone
- (503) 292-4066
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1713945
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Aug 27, 2026 | New notice | Indefinite | $80,000 | 2 | Aug 2, 2026 | sec.gov | |
| Mar 11, 2025 | New notice | $4,450,000 | $35,000 | $4,415,000 | 2 | Jan 19, 2025 | sec.gov |
| Sep 23, 2024 | Amendment | Indefinite | $150,000 | 3 | Jun 3, 2024 | sec.gov | |
| Jun 12, 2024 | New notice | $2,800,000 | $50,000 | $2,750,000 | 2 | Jun 3, 2024 | sec.gov |
| Nov 8, 2023 | New notice | Indefinite | $100,000 | 2 | Oct 31, 2023 | sec.gov | |
| Apr 15, 2022 | New notice | $5,000,000 | $250,000 | $4,750,000 | 1 | Apr 8, 2022 | sec.gov |
| Apr 29, 2019 | Amendment | $3,000,000 | $1,945,773 | $1,054,227 | 10 | May 21, 2018 | sec.gov |
| May 25, 2018 | New notice | $2,000,000 | $800,000 | $1,200,000 | 1 | May 21, 2018 | sec.gov |
| Aug 4, 2017 | New notice | $2,000,000 | $200,000 | $1,800,000 | 2 | Jul 21, 2017 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Bernard Fox, Ph.D. | Executive Officer, Director | |
| Hong-Ming Hu, Ph.D. | Executive Officer, Director | |
| Bernard A. Fox, III | Executive Officer | |
| Sung Poblete, R.N., Ph.D. | Director |
Other biotechnology companies in Oregon that filed recently
- Trace Biosciences Inc. $8.3 million · Aug 12, 2026
Every Form D from the week of Aug 24, 2026 · All recent filings in Oregon · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what UBIVAC, INC. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.